Secondary Logo

Journal Logo

July/August 2019 - Volume 42 - Issue 6

  • Steven A. Rosenberg, MD, PhD
  • 1524-9557
  • 1537-4513
  • 9 issues per year
  • Oncology 79/217
    Immunology 55/150
    Medicine, Research, and Experimental 37/128
  • 3.826

Current Issue Highlights



Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program

Bisschop, Cornelis; Wind, Thijs T.; Blank, Christian U.; More

Journal of Immunotherapy. 42(6):208-214, July/August 2019.